A Split-face, Randomized,controlled Trial Comparing Efficacy of 2940 nanometer Erbium YAG laser Combined with Triple Combination Cream Versus the Cream Alone for the Treatment of Melasma in Asians
Phase 2
Recruiting
- Conditions
- Melasma
- Registration Number
- TCTR20180814006
- Lead Sponsor
- Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with melasma
Exclusion Criteria
-pregnancy
-allergic to Hydroquinone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method melasma 0,4,8,12 weeks Photograph
- Secondary Outcome Measures
Name Time Method skin color 0,4,8,12 weeks Photograph